{
  "emaEpar": [],
  "fdaDrugLabel": [],
  "id": "Baloramotide",
  "nciThesaurus": {
    "casRegistry": "2207581-19-7",
    "chebiId": "",
    "chemicalFormula": "",
    "definition": "A genetically engineered synthetic protein, Recombinant NY-ESO-1 Protein (Cancer-Testis Tumor Antigen Family) elicits strong humoral and cellular immune responses to NY-ESO-1-expressing cancers and is used to produce specific vaccines to increase the immune response against tumors. NY-ESO-1 epitopes presented by human HLA are recognized by CD4(+) T lymphocytes in patients with NY-ESO-1-expressing melanoma.",
    "fdaUniiCode": "9T6PW6J6MA",
    "identifier": "C38143",
    "preferredName": "Baloramotide",
    "semanticType": "Amino Acid, Peptide, or Protein",
    "subclassOf": [
      "C2835"
    ],
    "synonyms": [
      "BALORAMOTIDE",
      "Baloramotide",
      "Cancer/testis Antigen 1, Recombinant",
      "Recombinant NY-ESO-1 Protein"
    ]
  }
}